Skip to main content

Published locations for AFib, CVD risks similar after ustekinumab and TNF inhibitors in psoriatic patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. AFib, CVD risks similar after ustekinumab and TNF inhibitors in psoriatic patients

User login

  • Reset your password
  • /content/afib-cvd-risks-similar-after-ustekinumab-and-tnf-inhibitors-psoriatic-patients
  • /edermatologynews/article/198478/psoriasis/afib-cvd-risks-similar-after-ustekinumab-and-tnf
  • /rheumatologynews/article/198478/psoriasis/afib-cvd-risks-similar-after-ustekinumab-and-tnf
  • /rheumatology/article/198478/psoriasis/afib-cvd-risks-similar-after-ustekinumab-and-tnf-inhibitors
  • /dermatology/article/198478/psoriasis/afib-cvd-risks-similar-after-ustekinumab-and-tnf-inhibitors
  • /dermatology/psoriasiscollection/article/198478/psoriasis/afib-cvd-risks-similar-after-ustekinumab
  • /psoriatic-arthritis-icymi/article/198478/psoriasis/afib-cvd-risks-similar-after-ustekinumab-and-tnf